P52
SGXSingapore O&G Ltd
Health CareSingapore
Financial Summary
| Metric | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Revenue | $898.4M | $812.3M | $774.1M | $703.3M |
| EBITDA | - | - | - | - |
| Net Profit | $50.7M | $40.9M | $36.3M | $23.4M |
| EPS | - | - | - | - |
| DPS | - | - | - | - |
Balance Sheet
Total Assets$339.5M
Total Liabilities-
Equity$290.7M
Net Debt$-51.0M
Cash$99.8M
NTA/Share-
FY25
Price Chart
Insufficient price data
Key Metrics
P/E Ratio23.57
P/B Ratio3.98
EV/EBITDA10.86
Dividend Yield2.0%
ROE18.1%
ROA8.3%
Net Margin5.7%
Debt/Equity0.16
Net Debt/EBITDA-0.50
FCF Yield-
Governance Score
-
SGX Code of Corporate Governance
StocksSG provides data for informational purposes only. This is not financial advice. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.